What's new

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 6, Status: Authorised

Apr 23, 2025 - 15:35
 0
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

These Are The Best Countries To Drive In

Next Article

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab...

Related Posts

Summary of opinion: Tremfya, 27/03/2025 Positive

Summary of opinion: Tremfya, 27/03/2025 Positive

Mar 28, 2025  0

Medicines for human use under evaluation

Medicines for human use under evaluation

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0